Gennao Bio
Gene monoclonal antibody platform for nucleic acid therapeutic delivery to target cells
- Sector
- Biotech
- Headquarters
- Pennington, NJ
- Founded
- 2020
- Latest Form D
- $15M, Dec 2022
- Total capital
- $25M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $25M
- 2 Form D · last Dec 2022
- 47 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 29 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$15M
- Private capital raisedForm D · SEC · 1st filing$10M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Anuj GoswamiExecutive OfficerNamed in SEC Form D filings
- Bradley CampbellDirectorNamed in SEC Form D filings
- Bruce TurnerDirectorNamed in SEC Form D filings
- Chau KhuongDirectorNamed in SEC Form D filings
- Chris DukeExecutive OfficerNamed in SEC Form D filings
- Claudine ProwseExecutive OfficerNamed in SEC Form D filings
Show all 13 people
- Craig GordonDirectorNamed in SEC Form D filings
- Dale LudwigExecutive OfficerNamed in SEC Form D filings
- Gary SenderDirectorNamed in SEC Form D filings
- Joe McIntoshExecutive OfficerNamed in SEC Form D filings
- Julie HambletonDirectorNamed in SEC Form D filings
- Peter ThompsonDirectorNamed in SEC Form D filings
- Stephen SquintoExecutive Officer, Director, PromoterNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 29- PendingCompositions And Methods For Delivering Therapeutic Polynucleotides For Exon SkippingUSPTOApplication 18841356
- PendingCompositions And Methods For Treating DiseaseUSPTOApplication 18841043
- PendingCompositions And Methods For Delivery Of Nucleic Acids To CellsUSPTOApplication 18255753
Show all 29 patent records
- Compositions And Methods For Delivering Therapeutic Polynucleotides For Exon SkippingMay 29, 2025 · Application 18841356Pending
- Compositions And Methods For Treating DiseaseMay 22, 2025 · Application 18841043Pending
- Compositions And Methods For Delivery Of Nucleic Acids To CellsJun 13, 2024 · Application 18255753Pending
- Compositions And Methods For Delivering Therapeutic PolynucleotidesJun 6, 2024 · Application 18548827Pending
- Humanized 3E10 Antibodies, Variants, And Antigen Binding Fragments ThereofSep 28, 2023 · Application 18177571Pending
- Antibody Drug ConjugatesApplication 63513065Pending
- Antibody Drug ConjugatesApplication 63477364Pending
- Compositions And Methods For Treating CancersApplication PCTUS2022036143Pending
- Humanized 3E10 Antibodies, Variants, And Antigen Binding Fragments ThereofApplication 63316338Pending
- Compositions And Methods For Delivering Therapeutic Polynucleotides For Exon SkippingApplication 63316339Pending
- Compositions And Methods For Delivering Therapeutic PolynucleotidesApplication PCTUS2022018789Pending
- Compositions And Methods For Treating Skeletal Muscle DiseaseApplication PCTUS2022018780Pending
- Compositions And Methods For Treating DiseaseApplication 63316347Pending
- Compositions And Methods For Treating DiseaseApplication 63316341Pending
- Compositions And Methods For Treating Cancers Of The Central Nervous SystemApplication 63297538Pending
- Compositions And Methods For Treating Skeletal Muscle DiseaseApplication 63297504Pending
- Compositions And Methods For Treating CancersApplication 63297542Pending
- Compositions And Methods For Delivery Of Nucleic Acids To CellsApplication PCTUS2021048552Pending
- Compositions And Methods For Treating CancersApplication 63239372Pending
- Compositions And Methods For Treating Cancers Of The Central Nervous SystemApplication 63218970Pending
- Compositions And Methods For Treating Cancers Of The Central Nervous SystemApplication 63217926Pending
- Compositions And Methods For Treating Skeletal Muscle DiseaseApplication 63156060Pending
- Compositions And Methods For Delivering Therapeutic PolynucleotidesApplication 63156070Pending
- Antibody Drug ConjugatesApplication 19144384Pending
- Compositions And Methods For Delivery Of Nucleic Acids To CellsApplication 63121782Pending
- Antibody Drug ConjugatesApplication 63667450Pending
- Antibody Drug ConjugatesApplication 63574739Pending
- Antibody Drug ConjugatesApplication 63585915Pending
- Antibody Drug ConjugatesApplication 63580921Pending
Related companies, and why
- SmartCells, IncSimilar federal contract value in Biotech · null in contracts
- Halodine LLCSimilar federal contract value in Biotech · null in contracts
- Osmol TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Pacylex Pharmaceuticals Inc.Similar federal contract value in Biotech · null in contracts
- Angstrom Bio, Inc.Similar federal contract value in Biotech · null in contracts
- Aliada TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .